| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |